INTS (Intensity Therapeutics) Revenue Growth QoQ

Brandmark of Intensity Tx (INTS)

Intensity Therapeutics is developing cancer immunotherapy via the DITA platform, where patent potential may offset testing costs. Environmental regulations require the company to implement energy-saving measures, while AI modules automate data collection. The GURU.Markets terminal provides the quarterly revenue change history, where 0.00 reflects the latest metric value, linking market capitalization to actual sales.

intensitytherapeutics.com (INTS) - Revenue Change vs Previous Quarter from 02/21/2024 to 11/20/2026

Analytical breakdowns for Intensity Tx (INTS)

Basic company analysis:INTS - Intensity Tx
Manufactured products of Intensity Therapeutics Inc

Intensity Therapeutics is optimizing costs by delegating production to international contract manufacturing organizations to ensure uninterrupted drug supplies. By analyzing quarterly revenue growth dynamics, an investor assesses the pace of income expansion over three months, which allows for the rapid identification of an operational downturn or the confirmation of a recovery growth stage, thereby determining the fundamental viability and investment attractiveness of the business.

Competing companies

IBRX - Revenue Growth QoQ|IMCR (immunocore.com) - Sales Growth QoQ|Janux Corp (JANX) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Arcus Bio (RCUS)|Quarterly Sales Growth ZYME|TNGX - Revenue Change vs Previous Quarter|Quarterly Sales Growth IOVA (Iovance)|Sales Change QoQ IMTX|Quarterly Revenue Growth XNCR (Xencor)|Quarterly Revenue Increase CMPX|replimune.com - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Lyell Pharma|Innate Pharma S.A. (IPHA) - Revenue Growth QoQ|Pyxis Oncology Inc. - Quarterly Revenue Increase|CGEN (Compugen Limited) - Quarterly Revenue Growth|Quarterly Revenue Growth IO Biotech Inc|Revenue Growth QoQ Sutro Biopharma (STRO)|INKT: Revenue Dynamics QoQ|Werewolf Therapeutics, Inc. - Quarterly Sales Growth|Immix (IMMX) - Quarterly Revenue Growth Rate|ALX Oncology Holdings Inc. - Quarterly Revenue Growth|CUE - Quarterly Revenue Growth|PDSB: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Quarterly Revenue Growth|Quarterly Sales Growth Liminatus Pharma (LIMN)|Quarterly Revenue Growth LVTX|Sales Change QoQ NXTC|Leap Therapeutics, Inc. - Quarterly Sales Growth|Sensei Bio (SNSE) - Quarterly Revenue Growth Rate|TOVX: Quarterly Sales Growth|Gritstone bio - Sales Change QoQ|Kineta Bio (KA) - Revenue Growth QoQ|NexImmune Inc (NEXI) - Quarterly Revenue Growth|Revenue Growth QoQ Turnstone Biologics Corp.|Sales Growth QoQ VCNX (Vaccinex, Inc.)|Quarterly Sales Growth HARP (Harpoon Tx)